APO Research
Talk to an analyst

APO RESEARCH · REPORT

Class Ⅱ AI Medical Imaging Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Class Ⅱ AI Medical Imaging Software Market Outlook and Growth Opportunities 2026

25 December 2025196 pages

Choose your research edition.

Industry ResearchClass Ⅱ AI Medical Imaging Software Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Class Ⅱ AI Medical Imaging Software Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Class Ⅱ AI Medical Imaging Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Class Ⅱ AI Medical Imaging Software Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Class Ⅱ AI Medical Imaging Software Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Class Ⅱ AI Medical Imaging Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Class Ⅱ AI Medical Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Class Ⅱ AI Medical Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Class Ⅱ AI Medical Imaging Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Class Ⅱ AI Medical Imaging Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Class Ⅱ AI Medical Imaging Software market include Airdoc, Yizhun Intelligent, Infervision Medical, Shukun Technology, Deepwise, Fosun Aitrox and Diagens Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Class Ⅱ AI Medical Imaging Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Class Ⅱ AI Medical Imaging Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Class Ⅱ AI Medical Imaging Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Class Ⅱ AI Medical Imaging Software market.

Class Ⅱ AI Medical Imaging Software Segment by Company

Airdoc

Yizhun Intelligent

Infervision Medical

Shukun Technology

Deepwise

Fosun Aitrox

Diagens Biotechnology

Class Ⅱ AI Medical Imaging Software Segment by Type

Pulmonary

Cerebral

Cardiovascular

Others

Class Ⅱ AI Medical Imaging Software Segment by Application

Hospital

Clinic

Class Ⅱ AI Medical Imaging Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Class Ⅱ AI Medical Imaging Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Class Ⅱ AI Medical Imaging Software key companies, revenue, market share, and recent developments.

3. To split the Class Ⅱ AI Medical Imaging Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Class Ⅱ AI Medical Imaging Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Class Ⅱ AI Medical Imaging Software significant trends, drivers, influence factors in global and regions.

6. To analyze Class Ⅱ AI Medical Imaging Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Class Ⅱ AI Medical Imaging Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Class Ⅱ AI Medical Imaging Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Class Ⅱ AI Medical Imaging Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Class Ⅱ AI Medical Imaging Software industry.

Chapter 3: Detailed analysis of Class Ⅱ AI Medical Imaging Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Class Ⅱ AI Medical Imaging Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Class Ⅱ AI Medical Imaging Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Class Ⅱ AI Medical Imaging Software Industry Trends Table 2. Class Ⅱ AI Medical Imaging Software Industry Drivers Table 3. Class Ⅱ AI Medical Imaging Software Industry Opportunities and Challenges Table 4. Class Ⅱ AI Medical Imaging Software Industry Restraints Table 5. Global Class Ⅱ AI Medical Imaging Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Class Ⅱ AI Medical Imaging Software Revenue Share by Company (2021-2026) Table 7. Global Class Ⅱ AI Medical Imaging Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Class Ⅱ AI Medical Imaging Software Key Company Manufacturing Base & Headquarters Table 9. Global Class Ⅱ AI Medical Imaging Software Company, Product Type & Application Table 10. Global Class Ⅱ AI Medical Imaging Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Class Ⅱ AI Medical Imaging Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Pulmonary Table 15. Significant Companies of Cerebral Table 16. Significant Companies of Cardiovascular Table 17. Significant Companies of Others Table 18. Global Class Ⅱ AI Medical Imaging Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Class Ⅱ AI Medical Imaging Software Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Class Ⅱ AI Medical Imaging Software Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Type (2021-2026) Table 22. Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Clinic Table 25. Global Class Ⅱ AI Medical Imaging Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Class Ⅱ AI Medical Imaging Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Class Ⅱ AI Medical Imaging Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Application (2021-2026) Table 29. Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Application (2027-2032) Table 30. Global Class Ⅱ AI Medical Imaging Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Class Ⅱ AI Medical Imaging Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Region (2021-2026) Table 33. Global Class Ⅱ AI Medical Imaging Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Region (2027-2032) Table 35. Global Class Ⅱ AI Medical Imaging Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Class Ⅱ AI Medical Imaging Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Class Ⅱ AI Medical Imaging Software Sales Value Market Share by Country (2021-2026) Table 38. Global Class Ⅱ AI Medical Imaging Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Class Ⅱ AI Medical Imaging Software Sales Value Market Share by Country (2027-2032) Table 40. Airdoc Company Information Table 41. Airdoc Business Overview Table 42. Airdoc Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Airdoc Class Ⅱ AI Medical Imaging Software Product Portfolio Table 44. Airdoc Recent Development Table 45. Yizhun Intelligent Company Information Table 46. Yizhun Intelligent Business Overview Table 47. Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Product Portfolio Table 49. Yizhun Intelligent Recent Development Table 50. Infervision Medical Company Information Table 51. Infervision Medical Business Overview Table 52. Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Infervision Medical Class Ⅱ AI Medical Imaging Software Product Portfolio Table 54. Infervision Medical Recent Development Table 55. Shukun Technology Company Information Table 56. Shukun Technology Business Overview Table 57. Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Shukun Technology Class Ⅱ AI Medical Imaging Software Product Portfolio Table 59. Shukun Technology Recent Development Table 60. Deepwise Company Information Table 61. Deepwise Business Overview Table 62. Deepwise Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Deepwise Class Ⅱ AI Medical Imaging Software Product Portfolio Table 64. Deepwise Recent Development Table 65. Fosun Aitrox Company Information Table 66. Fosun Aitrox Business Overview Table 67. Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Fosun Aitrox Class Ⅱ AI Medical Imaging Software Product Portfolio Table 69. Fosun Aitrox Recent Development Table 70. Diagens Biotechnology Company Information Table 71. Diagens Biotechnology Business Overview Table 72. Diagens Biotechnology Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Diagens Biotechnology Class Ⅱ AI Medical Imaging Software Product Portfolio Table 74. Diagens Biotechnology Recent Development Table 75. Research Programs/Design for This Report Table 76. Authors List of This Report Table 77. Secondary Sources Table 78. Primary Sources List of Figures Figure 1. Class Ⅱ AI Medical Imaging Software Product Image Figure 2. Global Class Ⅱ AI Medical Imaging Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Class Ⅱ AI Medical Imaging Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Class Ⅱ AI Medical Imaging Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Pulmonary Image Figure 8. Cerebral Image Figure 9. Cardiovascular Image Figure 10. Others Image Figure 11. Global Class Ⅱ AI Medical Imaging Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Class Ⅱ AI Medical Imaging Software Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Clinic Image Figure 16. Global Class Ⅱ AI Medical Imaging Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Class Ⅱ AI Medical Imaging Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Application (2021-2032) Figure 19. Global Class Ⅱ AI Medical Imaging Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Class Ⅱ AI Medical Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Class Ⅱ AI Medical Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Class Ⅱ AI Medical Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Class Ⅱ AI Medical Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Class Ⅱ AI Medical Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Class Ⅱ AI Medical Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Class Ⅱ AI Medical Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Class Ⅱ AI Medical Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Class Ⅱ AI Medical Imaging Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Class Ⅱ AI Medical Imaging Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Pulmonary
  • Cerebral
  • Cardiovascular
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Airdoc
  • Yizhun Intelligent
  • Infervision Medical
  • Shukun Technology
  • Deepwise
  • Fosun Aitrox
  • Diagens Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Class Ⅱ AI Medical Imaging Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Class Ⅱ AI Medical Imaging Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Class Ⅱ AI Medical Imaging Software Market Dynamics
  1. 2.1 Class Ⅱ AI Medical Imaging Software Industry Trends
  2. 2.2 Class Ⅱ AI Medical Imaging Software Industry Drivers
  3. 2.3 Class Ⅱ AI Medical Imaging Software Industry Opportunities and Challenges
  4. 2.4 Class Ⅱ AI Medical Imaging Software Industry Restraints
3 Class Ⅱ AI Medical Imaging Software Market by Company
  1. 3.1 Global Class Ⅱ AI Medical Imaging Software Company Revenue Ranking in 2025
  2. 3.2 Global Class Ⅱ AI Medical Imaging Software Revenue by Company (2021-2026)
  3. 3.3 Global Class Ⅱ AI Medical Imaging Software Company Ranking (2024-2026)
  4. 3.4 Global Class Ⅱ AI Medical Imaging Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Class Ⅱ AI Medical Imaging Software Company Product Type and Application
  6. 3.6 Global Class Ⅱ AI Medical Imaging Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Class Ⅱ AI Medical Imaging Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Class Ⅱ AI Medical Imaging Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Class Ⅱ AI Medical Imaging Software Market by Type
  1. 4.1 Class Ⅱ AI Medical Imaging Software Type Introduction
  2. 4.1.1 Pulmonary
  3. 4.1.2 Cerebral
  4. 4.1.3 Cardiovascular
  5. 4.1.4 Others
  6. 4.2 Global Class Ⅱ AI Medical Imaging Software Sales Value by Type
  7. 4.2.1 Global Class Ⅱ AI Medical Imaging Software Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Class Ⅱ AI Medical Imaging Software Sales Value by Type (2021-2032)
  9. 4.2.3 Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Type (2021-2032)
5 Class Ⅱ AI Medical Imaging Software Market by Application
  1. 5.1 Class Ⅱ AI Medical Imaging Software Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Class Ⅱ AI Medical Imaging Software Sales Value by Application
  5. 5.2.1 Global Class Ⅱ AI Medical Imaging Software Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Class Ⅱ AI Medical Imaging Software Sales Value by Application (2021-2032)
  7. 5.2.3 Global Class Ⅱ AI Medical Imaging Software Sales Value Share by Application (2021-2032)
6 Class Ⅱ AI Medical Imaging Software Regional Value Analysis
  1. 6.1 Global Class Ⅱ AI Medical Imaging Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Class Ⅱ AI Medical Imaging Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Class Ⅱ AI Medical Imaging Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Class Ⅱ AI Medical Imaging Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Class Ⅱ AI Medical Imaging Software Sales Value (2021-2032)
  7. 6.3.2 North America Class Ⅱ AI Medical Imaging Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Class Ⅱ AI Medical Imaging Software Sales Value (2021-2032)
  10. 6.4.2 Europe Class Ⅱ AI Medical Imaging Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Class Ⅱ AI Medical Imaging Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Class Ⅱ AI Medical Imaging Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Class Ⅱ AI Medical Imaging Software Sales Value (2021-2032)
  16. 6.6.2 South America Class Ⅱ AI Medical Imaging Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Class Ⅱ AI Medical Imaging Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Class Ⅱ AI Medical Imaging Software Sales Value Share by Country, 2025 VS 2032
7 Class Ⅱ AI Medical Imaging Software Country-level Value Analysis
  1. 7.1 Global Class Ⅱ AI Medical Imaging Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Class Ⅱ AI Medical Imaging Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Class Ⅱ AI Medical Imaging Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Class Ⅱ AI Medical Imaging Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Class Ⅱ AI Medical Imaging Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Class Ⅱ AI Medical Imaging Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Class Ⅱ AI Medical Imaging Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Airdoc
  2. 8.1.1 Airdoc Company Information
  3. 8.1.2 Airdoc Business Overview
  4. 8.1.3 Airdoc Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Airdoc Class Ⅱ AI Medical Imaging Software Product Portfolio
  6. 8.1.5 Airdoc Recent Developments
  7. 8.2 Yizhun Intelligent
  8. 8.2.1 Yizhun Intelligent Company Information
  9. 8.2.2 Yizhun Intelligent Business Overview
  10. 8.2.3 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Product Portfolio
  12. 8.2.5 Yizhun Intelligent Recent Developments
  13. 8.3 Infervision Medical
  14. 8.3.1 Infervision Medical Company Information
  15. 8.3.2 Infervision Medical Business Overview
  16. 8.3.3 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Infervision Medical Class Ⅱ AI Medical Imaging Software Product Portfolio
  18. 8.3.5 Infervision Medical Recent Developments
  19. 8.4 Shukun Technology
  20. 8.4.1 Shukun Technology Company Information
  21. 8.4.2 Shukun Technology Business Overview
  22. 8.4.3 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shukun Technology Class Ⅱ AI Medical Imaging Software Product Portfolio
  24. 8.4.5 Shukun Technology Recent Developments
  25. 8.5 Deepwise
  26. 8.5.1 Deepwise Company Information
  27. 8.5.2 Deepwise Business Overview
  28. 8.5.3 Deepwise Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Deepwise Class Ⅱ AI Medical Imaging Software Product Portfolio
  30. 8.5.5 Deepwise Recent Developments
  31. 8.6 Fosun Aitrox
  32. 8.6.1 Fosun Aitrox Company Information
  33. 8.6.2 Fosun Aitrox Business Overview
  34. 8.6.3 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Product Portfolio
  36. 8.6.5 Fosun Aitrox Recent Developments
  37. 8.7 Diagens Biotechnology
  38. 8.7.1 Diagens Biotechnology Company Information
  39. 8.7.2 Diagens Biotechnology Business Overview
  40. 8.7.3 Diagens Biotechnology Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Diagens Biotechnology Class Ⅱ AI Medical Imaging Software Product Portfolio
  42. 8.7.5 Diagens Biotechnology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst